# EDGAR Filing Document

**Accession Number:** 0001626644
**File Stem:** 0001683168-25-005637
**Filing Date:** 2025-8
**Character Count:** 8408
**Document Hash:** a63132f64a97d4675acaf4459c973bac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-005637.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0001683168-25-005637

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250731

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250804

**DATE AS OF CHANGE**: 20250804

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Odyssey Health, Inc.
- **CENTRAL INDEX KEY:** 0001626644
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 471022125
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56196
- **FILM NUMBER:** 251181296

**BUSINESS ADDRESS:**
- **STREET 1:** 2300 WEST SAHARA AVENUE
- **STREET 2:** SUITE 800-#4012
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89102
- **BUSINESS PHONE:** 702-780-6559

**MAIL ADDRESS:**
- **STREET 1:** 2300 WEST SAHARA AVENUE
- **STREET 2:** SUITE 800-#4012
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Odyssey Group International, Inc.
- **DATE OF NAME CHANGE:** 20141128

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: **July 31, 2025**

(Date of earliest event reported)

**<u>ODYSSEY HEALTH, INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **<u>Nevada</u>** | **<u>000-56196</u>** | **<u>47-1022125</u>** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) |

---

---

| | |
|:---|:---|
| **<u>2300 West Sahara Avenue, Suite 800 - #4012,<br> Las Vegas, NV</u>** | **<u>89102</u>** |
| (Address of principal executive offices) | (Zip Code) |

---

**<u>(702) 780-6559</u>**

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| N/A | N/A | N/A |

---

**Securities registered pursuant to Section 12(g) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each Class** | **Trading Symbol** | **Name of Each Exchange on Which Registered** |
| Common Stock ($0.001 par value) | ODYY | OTC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 1.01.** | **Entry into a Material Definitive Agreement.** |

---

On July 31, 2025, Odyssey Health, Inc., entered into four Promissory Note Amendments No. 11 (the "Amendments"), to the Promissory Notes entered into December 21, 2021 and December 22, 2021 and as amended April 20, 2022, June 3, 2022, September 30, 2022, December 30, 2022, March 31, 2023, June 30, 2023, November 1, 2023, January 31, 2024, July 31, 2024, and January 31, 2025, with two directors and two officers of the Company. Pursuant to the Amendments, the parties have agreed to extend the maturity date of the note to January 31, 2026. All other terms and conditions remain the same.

Form of Amendment No. 11 to the Promissory Note, is attached as Exhibit 10.1 to this Current Report on Form is and is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 2.03.** | **Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.** |

---

The information set forth above under Item 1.01 is hereby incorporated by reference into this Item 2.03.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

**(d) Exhibits.**

Number Exhibit <br> 10.1 [Form of Amendment No. 11 to Promissory Note](odyssey_ex1001.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Odyssey Health, Inc.** | **Odyssey Health, Inc.** |
| Date: August 4, 2025 | By: | /s/ Joseph Michael Redmond |
|  |  | Joseph Michael Redmond <br> Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**Amendment #11 to<br> Promissory Note**

This AMENDMENT (this "**AMENDMENT**") is entered into by and between the Company and Holder (each as defined below), effective as of July 31, 2025 (the "**Effective Date**"), and binding on the undersigned parties as of that date.

Odyssey Health, Inc. formerly Odyssey Group International, Inc. ("**BORROWER**") and ____________ ("**LENDER**") entered into that certain Promissory Note (the "**Note**") dated December 22, 2021, as amended April 20, 2022, June 3, 2022, September 30, 2022, December 30, 2022, March 31, 2023, June 30, 2023, November 1, 2023, January 31, 2024, July 31, 2024, and January 31, 2025 in the amount of $25,000.00 (the "**Loan Amount**"). Capitalized terms not otherwise defined have the meaning set forth in the Note.

**Whereas**, the parties have agreed to extend the maturity date of the Note subject to the conditions contained herein.

**AGREEMENT**

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree as follows:

**1.** **<u>Extension of Maturity Date</u>**. The Maturity Date of the Note is amended and extended to January 31, 2026.

**2.** **<u>Effectiveness; Conflict</u>**. Except as modified hereby, the Note and terms thereof shall remain in full force and effect. On and after the effectiveness of this Amendment, each reference in the Notes to "this Agreement," "hereunder," "hereof," "herein" or words of like import shall mean and be a reference to the Note, as amended by this Amendment. To the extent the terms of this Amendment conflict with any provision of the Note or any of the documents referenced therein, then the provisions of this Amendment shall control.

**3.** **<u>Counterparts</u>**. This Amendment may be executed by facsimile transmission and in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.

**4.<u>All Other Terms</u>.** All other terms and conditions of the Note remain unchanged and in full force and effect.

**IN WITNESS WHEREOF,** and acknowledging acceptance and agreement of the foregoing, BORROWER, and LENDER affix their signatures hereto,

---

| | |
|:---|:---|
| **Odyssey Health, Inc.** | **Lender** |
| *<u>/s/ J. Michael Redmond</u>* | *<u>/s/ Lender</u>* |
| By: J. Michael Redmond | By: _________________________ |
| Title: President | An Individual |
| Dated: July 31, 2025 | Dated: July 31, 2025 |

---